TALS - Talaris Therapeutics appoints current CFO Mary Kay as interim CEO
2023-05-26 07:32:18 ET
- Talaris Therapeutics ( NASDAQ: TALS ) put its CFO in charge on Friday, replacing a CEO Scott Requadt, who will be leaving the Company as part of a planned workforce reduction, as previously announced by the Company.
- CFO Mary Kay Fenton has been named interim CEO with immediate effect.
- The company is currently conducting a comprehensive review of strategic alternatives focused on maximizing shareholder value, including possible business combinations and/or a divestiture of the Company’s cell therapy CMC capabilities. Source: Press Release
For further details see:
Talaris Therapeutics appoints current CFO Mary Kay as interim CEO